<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20090909002438N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-07-04</date_registration>
      <primary_sponsor>Guilan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of diclofenac on the treatment of fever in children</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of rectal diclofenac and high dose rectal acetaminophen on fever among children</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/39216</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be randomly divided into two groups of 45 children. All children aged 1 to 6 years who meet the inclusion criteria will be included in the study based on 22 random blocks of size 4 and one block of size 2 in a sealed envelope. The name of children will be expelled from the envelopes gradually, Blinding description: The patient is not aware of the type of medication he receives, nor is the person who measures the temperature.</study_design>
      <phase>3</phase>
      <hc_freetext>Fever.</hc_freetext>
      <i_freetext>Intervention 1: Control group: These children will receive acetaminophen suppository at a dose of 30 mg / kg. The acetaminophen suppositories 125 and 325 mg are manufactured by Daroupakhsh Pharmaceutical MFG Co., Lot/Batch Number: 304 &amp; 622, respectively. Based on the child’s weight, the suppositories will be cut off of length according to the required amount and will be weighted by a digital scale (Notebook series- Model: 1108-2 manufactured by Shenzhen Big Dipper Co., LTD., China); and then will be used. The rectal temperature of the patients will be measured before and then, one and three hours after the intervention, using the Beurer Digital Thermometer, FT15 / 1, manufactured by Beurer GmbH, Germany. Intervention 2: Intervention group: These children will receive diclofenac suppository at a dose of 1 mg / kg. The diclofenac suppositories 50 mg are manufactured by Daroupakhsh Pharmaceutical MFG Co., Lot/Batch Number: 873. Based on the child’s weight, the suppositories will be cut off of length according to the required amount and will be weighted by a digital scale (Notebook series- Model: 1108-2 manufactured by Shenzhen Big Dipper Co., LTD., China); and then will be used. The rectal temperature of the patients will be measured before and then, one and three hours after the intervention, using the Beurer Digital Thermometer, FT15 / 1, manufactured by Beurer GmbH, Germany.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Individual data related to primary outcome can be shared after making the data anonymous

When:
Starting 6 months after publication

To whom:
Only available for people working in academic institutions.

Conditions:
The use of data from this study is permitted for academic use and should be cited in the paper.

Where to obtain:
Request only by email to researcher: hashemian@gums.ac.ir

How to obtain:
The request must be submitted with the full individual and academic information of the applicant. Then the case is presented to the research committee at the presence of all the researchers and the data will be sent if approved.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Houman Hashemian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Pediatric Diseases Research Center, 17 Shahrivar Hospital, Shahid Siadati street, Namjoo street</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4144654679</zip>
        <telephone>+98 13 3336 9002</telephone>
        <email>hashemian@gums.ac.ir</email>
        <affiliation>Guilan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Houman Hashemian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Pediatric Diseases Research Center, 17 Shahrivar Hospital, Shahid Siadati St., Namjoo St., Rasht, Iran</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4144654679</zip>
        <telephone>+98 13 3336 9002</telephone>
        <email>hashemian@gums.ac.ir</email>
        <affiliation>Guilan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age of 1 to 6 years old
at least 10 kg weight
Fever between 39-40.5 ° C of rectal temperature lasted for less than 4 days</inclusion_criteria>
      <agemin>1 year</agemin>
      <agemax>6 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Diarrhea in the last 24 hours
History of previous sensitivity to acetaminophen and diclofenac
History of malignancy
History of renal failure
History of liver failure
History of neurological disease or febrile convulsion within the past hour, or loss of consciousness or known vasculitis
Use of antipyretic over the past 8 hours
Use of antibiotics within the past 8 hours or 3 hours after the administration of the active antipyretic drug (acetaminophen or diclofenac)
History of Hyper Reactive Airway Disease
History of gastritis and peptic ulcer</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R50.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Fever, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: These children will receive acetaminophen suppository at a dose of 30 mg / kg. The acetaminophen suppositories 125 and 325 mg are manufactured by Daroupakhsh Pharmaceutical MFG Co., Lot/Batch Number: 304 &amp; 622, respectively. Based on the child’s weight, the suppositories will be cut off of length according to the required amount and will be weighted by a digital scale (Notebook series- Model: 1108-2 manufactured by Shenzhen Big Dipper Co., LTD., China); and then will be used. The rectal temperature of the patients will be measured before and then, one and three hours after the intervention, using the Beurer Digital Thermometer, FT15 / 1, manufactured by Beurer GmbH, Germany.</i_keyword>
      <i_keyword>Intervention group: These children will receive diclofenac suppository at a dose of 1 mg / kg. The diclofenac suppositories 50 mg are manufactured by Daroupakhsh Pharmaceutical MFG Co., Lot/Batch Number: 873. Based on the child’s weight, the suppositories will be cut off of length according to the required amount and will be weighted by a digital scale (Notebook series- Model: 1108-2 manufactured by Shenzhen Big Dipper Co., LTD., China); and then will be used. The rectal temperature of the patients will be measured before and then, one and three hours after the intervention, using the Beurer Digital Thermometer, FT15 / 1, manufactured by Beurer GmbH, Germany.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Rate of patient temperature. Timepoint: Measure the temperature of the patients before, one and three hours after the intervention. Method of measurement: Digital rectal thermometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Guilan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-03-16</approval_date>
        <contact_name>Research Ethics Committee of Guilan University of Medical Sciences</contact_name>
        <contact_address>Vice-chancellor for Research, Guilan University of Medical Sciences, in front of 17 Shahrivar hospital, Shahid Siadati Street, Namjoo Street Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
